Gorham-Stout disease with life-threatening pleural effusion treated with a pleuro-peritoneal shunt: a case report

Leevi A Toivonen1, Marko H Neva1, Thanos Sioris2

  • 1Department of Orthopaedic and Trauma Surgery, Department of Internal Medicine.

Insights

Gorham-Stout disease (GSD) management can be improved with a multidisciplinary approach. A mini-invasive pleuro-peritoneal shunt effectively treated life-threatening pleural effusion in a GSD patient.

Area of Science:

  • Orthopedics
  • Rare Diseases
  • Oncology

Background:

  • Gorham-Stout disease (GSD) is a rare, aggressive bone disorder with unknown etiology.
  • Massive osteolysis and lymphatic proliferation characterize GSD.
  • Thoracic GSD can lead to life-threatening pleural effusion and neurological complications like paraparesis.

Purpose of the Study:

  • To report a case of thoracic Gorham-Stout disease with paraparesis and severe pleural effusion.
  • To highlight the successful management of pleural effusion using a pleuro-peritoneal shunt, a novel approach for GSD.
  • To investigate the potential role of interleukin-6 and bone resorption markers in monitoring GSD activity.

Main Methods:

  • Case report of a 23-year-old male with thoracic GSD.
  • Management involved a multidisciplinary team approach.
  • Treatment for pleural effusion utilized a mini-invasive pleuro-peritoneal shunt.

Main Results:

  • The patient experienced a good recovery following multidisciplinary management.
  • Pleuro-peritoneal shunting successfully resolved the life-threatening pleural effusion.
  • Interleukin-6 and bone resorption markers showed potential utility in assessing disease activity.

Conclusions:

  • A multidisciplinary approach is crucial for managing complex cases of Gorham-Stout disease.
  • Pleuro-peritoneal shunting offers a viable, minimally invasive option for GSD-related pleural effusion.
  • Biomarkers like IL-6 and bone resorption markers may aid in GSD activity monitoring.
Abstract

Related Concept Videos

Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Flail Chest-II01:26

Flail Chest-II

Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Pneumothorax-I01:26

Pneumothorax-I

A pneumothorax is a condition where air builds up in the space between the lung and the chest wall, causing the lung to collapse. This condition arises when air enters the space between the parietal and visceral pleura, disrupting the negative pressure essential for lung inflation. This can lead to a partial or complete collapse of the lung.
Pneumothorax can be even further classified as spontaneous, traumatic, and tension pneumothorax.
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Esophageal Perforation-II: Clinical Manifestations and Management01:28

Esophageal Perforation-II: Clinical Manifestations and Management

Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations: